Month: September 2025

BELTSVILLE, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it will participate in a fireside chat at the H.C. Wainwright 27th Annual Global Investment Conference in New York City on Monday, September 8th, at 4:00 pm ET. A live audio webcast will be available through the Investors section of the company’s website at www.nextcure.com. A replay of the webcast will be available after the event and archived on the website for 30 days. About NextCure, Inc.NextCure is a clinical-stage biopharmaceutical company that is focused on advancing innovative medicines that treat cancer patients that do not respond to, or have disease progression on, current...

MONTREAL, Sept. 04, 2025 (GLOBE NEWSWIRE) — Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company”) is pleased to announce that it has begun drilling at the Anatacau Main Project, located in the Eeyou-Istchee James Bay region of Quebec. The drill program will target the Anais lithium discovery, located 22 kilometers east and along strike from Rio Tinto’s Galaxy project and BRW’s Anatacau West project. Mr. Killian Charles, President and CEO of BRW, commented: “Beyond our favorable results in Greenland, we continue to advance our portfolio of assets in Quebec. We expect to complete our maiden resource estimate at Mirage in Q4 and, now, have begun an exciting new drill program at Anatacau Main, one of our first Canadian lithium discoveries. Our previous work at the neighbouring Anatacau West project...

WELLESLEY HILLS, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced details for the CLYM116 webcast event, which is set for Monday, September 29, 2025, at 8:00 a.m. ET. Climb Bio’s management team will be joined by leading nephrologist, Craig E. Gordon, MD, MS, who has over 20 years of experience treating patients with IgA nephropathy (IgAN). The event will highlight the Company’s CLYM116 program, a preclinical-stage monoclonal antibody targeting APRIL (A Proliferation-Inducing Ligand), a key driver of pathogenic B cell activity in autoimmune diseases. CLYM116 is being developed for the treatment of IgAN and is the only known anti-APRIL approach to employ a ‘sweeper’ mechanism of action, which facilitates...

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces that it is changing its name to Algernon Health. The planned name change reflects the Company’s recent announcement that it will be focusing on the Alzheimer’s Disease (AD) diagnostic market with plans to establish specialized neuroimaging clinics across North America as its lead program. The clinics will feature the latest technology of U.S. FDA-cleared, optimized brain-specific Positron Emission Tomography (PET) scanning systems to detect amyloid plaques in patients, providing significantly lower radiation compared to standard PET/CT machines currently in operation globally. The PET scans are covered by Medicare, Medicaid,...

® JERICHO, New York, Sept. 04, 2025 (GLOBE NEWSWIRE) — Kimco Realty® (NYSE: KIM) announced today that members of its management team will present at the BofA Securities 2025 Global Real Estate Conference on Wednesday, September 10, 2025. The webcast information is as follows: When: Wednesday, September 10, 2025 from 3:45 PM – 4:20 PM, ET Live Webcast: Kimco Realty Presentation Link Audio from the conference will be available on Kimco Realty’s investor relations website until December 10, 2025.   About Kimco Realty® Kimco Realty® (NYSE: KIM) is a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States. The company’s portfolio is strategically concentrated in the first-ring suburbs of the top major metropolitan markets,...

Drilling Continues to Highlight the Potential for Resource Growth at Enchi, Intersects High-Grade Gold Mineralization at the Pre-Resource Stage Kojina Hill Gold Target VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) — Newcore Gold Ltd. (“Newcore” or the “Company”) (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce additional drill results from the 35,000-metre drill program underway at the Company’s 100% owned Enchi Gold Project (“Enchi” or the “Project”) in Ghana. Shallow Reverse Circulation (“RC”) drilling at the Kojina Hill Gold Target (“Kojina Hill”) intersected multiple intervals of high-grade gold mineralization, including hole KJRC033 which intersected 184 grams per tonne gold (“g/t Au”) over 1.0 metre (“m”) from...

ALK (ALKB:DC / OMX: ALK B) today announced the decision to elevate its key commercial regions into the Executive Leadership Team (ELT) to further strengthen the execution of ALK’s strategy, Allergy+. Effective as of 1 October 2025, ALK’s two key commercial regions, Europe and North America, will be directly represented in the ELT. Dr. Flora Beiche-Scholz – who currently holds the position as Senior Vice President for region Europe – will join the ELT in a new position as Executive Vice President (EVP) and head of ALK’s Commercial Operations in Europe. The ELT will also be joined by a future EVP and head of Commercial Operations in North America. Until now, these two regions have been represented by EVP Søren Niegel. To secure a strong transition, the EVP position for North America will be held by Søren Niegel, until a permanent solution...

Company reinforces commitment to shareholders and capital markets access as it advances engineering, permitting, and financing milestones for its U.S. lithium refining project GREENWICH, Conn., Sept. 04, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (“Stardust Power” or the “Company”), an American developer of battery-grade lithium products, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company’s common stock. The Company’s stockholders previously approved the reverse stock split proposal at the Annual Meeting of Stockholders held on June 9, 2025, authorizing the Board to determine the exact ratio and timing. “Executing this reverse split is a strategic step forward for Stardust Power at this time. It allows the Company to attempt to regain full compliance with Nasdaq’s listing requirements,...

New Drilling Returns Longest Continuous Intercept to Date of 1117.5 Metres Averaging 0.25% Cu, 1.81 g/t Ag, and 0.022% Mo (0.35% CuEq) MONTREAL, Sept. 04, 2025 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company or “Osisko Metals“) (TSX: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce new drill results from the Gaspé Copper Project, located in the Gaspé Peninsula of Eastern Québec. Osisko Metals Chief Executive Officer Robert Wares commented: “Drill hole 30-1097 produced our longest intersection so far, returning 1117 metres of continuous mineralization from the top of Copper Mountain, located in the heart of the deposit. With 10 drills on site, we have completed over 65,000 metres of the drill program to date, and will continue the current program of infill and expansion drilling until December. The...